- SELLAS™ Life Sciences Receives FDA Fast Track Designation of Galinpepimut-S for the Treatment of Malignant Pleural Mesothelioma. SELLAS Life Sciences Group. Retrieved from: http://sellaslifesciences.com/2016/09/sellas-life-sciences-receives-fda-fast-track-designation-of-galinpepimut-s-for-the-treatment-of-malignant-pleural-mesothelioma/. Accessed: 09/30/16.
- Fast Track. U.S. Food & Drug Administration. Retrieved from: http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm. Accessed: 09/30/16.
- WT1 Cancer Vaccine. SELLAS Life Sciences Group. Retrieved from: http://sellaslifesciences.com/wt1-cancer-vaccine/. Accessed: 09/30/16.
Sources & Author